Cargando…

Killing SCLC: insights into how to target a shapeshifting tumor

Small cell lung cancer (SCLC) is a rapidly growing, highly metastatic, and relatively immune-cold lung cancer subtype. Historically viewed in the laboratory and clinic as a single disease, new discoveries suggest that SCLC comprises multiple molecular subsets. Expression of MYC family members and li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutherland, Kate D., Ireland, Abbie S., Oliver, Trudy G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973850/ https://www.ncbi.nlm.nih.gov/pubmed/35318269 http://dx.doi.org/10.1101/gad.349359.122

Ejemplares similares

Programming temporal shapeshifting
por: Hu, Xiaobo, et al.
Publicado: (2016)

Structural Studies on the Shapeshifting Murine Norovirus
por: Sherman, Michael B., et al.
Publicado: (2021)

Mycobacterium abscessus: Shapeshifter of the Mycobacterial World
por: Ryan, Keenan, et al.
Publicado: (2018)

Slippery ribosomes prefer shapeshifting mRNAs
por: Dinman, Jonathan D.
Publicado: (2019)

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)

Shapeshifting tau: from intrinsically disordered to paired-helical filaments
por: Mengham, Kurtis, et al.
Publicado: (2022)

Shapeshifting molecules: the story so far and the shape of things to come
por: Bismillah, Aisha N., et al.
Publicado: (2019)

Pathology and Classification of SCLC
por: Raso, Maria Gabriela, et al.
Publicado: (2021)

Among the shapeshifters: parasite-induced morphologies in ants (Hymenoptera, Formicidae) and their relevance within the EcoEvoDevo framework
por: Laciny, Alice
Publicado: (2021)

Promising Role of Circulating Tumor Cells in the Management of SCLC
por: De Luca, Antonella, et al.
Publicado: (2021)

What Are the Biomarkers for Immunotherapy in SCLC?
por: Longo, Vito, et al.
Publicado: (2021)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019)

Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis
por: Kwon, Min-chul, et al.
Publicado: (2015)

Important Shapeshifter: Mechanisms Allowing Astrocytes to Respond to the Changing Nervous System During Development, Injury and Disease
por: Schiweck, Juliane, et al.
Publicado: (2018)

Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria
por: Ottonello, Alessandra, et al.
Publicado: (2023)

What's New in SCLC? A Review
por: Oronsky, Bryan, et al.
Publicado: (2017)

Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021)

Shapeshifting in the Venus flytrap (Dionaea muscipula): Morphological and biomechanical adaptations and the potential costs of a failed hunting cycle
por: Durak, Grażyna M., et al.
Publicado: (2022)

Sonic Hedgehog in SCLC
por: Laukkanen, Mikko O., et al.
Publicado: (2015)

Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
por: Carpentier, Joséphine, et al.
Publicado: (2022)

Synthesis of NVCL-NIPAM Hydrogels Using PEGDMA as a Chemical Crosslinker for Controlled Swelling Behaviours in Potential Shapeshifting Applications
por: Tie, Billy Shu Hieng, et al.
Publicado: (2023)

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
por: Smith, Jarrod T., et al.
Publicado: (2020)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment
por: Bian, Xing, et al.
Publicado: (2019)

Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry
por: Pearsall, Sarah M., et al.
Publicado: (2023)

Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno
por: Brazel, Danielle, et al.
Publicado: (2023)

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance: Understanding SCLC heterogeneity and plasticity in metastasis and chemoresistance
por: Jin, Yujuan, et al.
Publicado: (2023)

Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion
por: Das, Millie, et al.
Publicado: (2021)

Durvalumab: A Review in Extensive-Stage SCLC
por: Al-Salama, Zaina T.
Publicado: (2021)

A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)
por: Oronsky, Bryan, et al.
Publicado: (2022)

Impact of Socioeconomic Factors on Overall Survival in SCLC
por: Roof, Logan, et al.
Publicado: (2022)

Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC
por: Mohan, Sumitra, et al.
Publicado: (2020)

How neutrophil metabolism affects bacterial killing
por: Toller-Kawahisa, Juliana E., et al.
Publicado: (2022)

To Kill or to Be Killed: How Does the Battle between the UPS and Autophagy Maintain the Intracellular Homeostasis in Eukaryotes?
por: Yu, Peifeng, et al.
Publicado: (2023)

Organoids as a Systems Platform for SCLC Brain Metastasis
por: Quaranta, Vito, et al.
Publicado: (2022)

Development and Validation of a Simplified Prognostic Score in SCLC
por: Negre, Elodie, et al.
Publicado: (2020)

Correction to: Durvalumab: A Review in Extensive-Stage SCLC
por: Al-Salama, Zaina T.
Publicado: (2021)

Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice
por: Richards, Donald, et al.
Publicado: (2015)

How Chloroform Kills
Publicado: (1859)

Cannot write session to /tmp/vufind_sessions/sess_v1tefhcltov0nep1kout2eu9rf